Literature DB >> 30233985

Use of Suture Button in the Treatment of Syndesmosis Injuries.

Mette Renate Andersen1, Wender Figved1.   

Abstract

A suture button device provides fixation of syndesmosis injuries of the ankle with or without concomitant malleolar fracture. The suture button device consists of a fiber thread attached between 2 small metal buttons. The buttons are placed on the cortical bone on the medial and lateral sides of the ankle, and the fiber thread is tightened to stabilize the syndesmosis. The suture button device offers stable yet dynamic fixation of the injured syndesmosis. The major steps of the procedure are (1) lateral skin incision straight to the bone; (2) open reduction and plate fixation of the fibular fracture if one is present; (3) reduction of the syndesmosis and temporary stabilization with a pin or clamp; (4) use of an appropriate burr to make a hole through 4 cortices at the level of the inferior tibiofibular joint, approximately 1.5 cm proximal to the ankle joint line and at a 20° to 30° lateral-to-anteromedial angle; (5) pulling the needle attached to the suture button device through the drill-hole from lateral to medial and flipping the small plate on the cortical bone of the medial cortex of the medial malleolus; (6) tightening the device by pulling the 2 threads on the lateral side with care taken to remove all of the slack from the system; and (7) checking placement and fixation with fluoroscopy, cutting the threads, and skin closure. Use of a walker boot or cast is decided on the basis of the fracture fixation. Partial weight-bearing is allowed for the first 6 weeks, after which full weight-bearing is permitted as pain allows. Routine removal of the suture button device is not required.

Entities:  

Year:  2018        PMID: 30233985      PMCID: PMC6143307          DOI: 10.2106/JBJS.ST.17.00050

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  8 in total

Review 1.  Conservative and surgical management of acute isolated syndesmotic injuries: ESSKA-AFAS consensus and guidelines.

Authors:  C Niek van Dijk; Umile Giuseppe Longo; Mattia Loppini; Pino Florio; Ludovica Maltese; Mauro Ciuffreda; Vincenzo Denaro
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-04       Impact factor: 4.342

2.  High complication rate after syndesmotic screw removal.

Authors:  Mette Renate Andersen; Frede Frihagen; Jan Erik Madsen; Wender Figved
Journal:  Injury       Date:  2015-08-21       Impact factor: 2.586

3.  A prospective randomized multicenter trial comparing clinical outcomes of patients treated surgically with a static or dynamic implant for acute ankle syndesmosis rupture.

Authors:  Mélissa Laflamme; Etienne L Belzile; Luc Bédard; Michel P J van den Bekerom; Mark Glazebrook; Stéphane Pelet
Journal:  J Orthop Trauma       Date:  2015-05       Impact factor: 2.512

Review 4.  An update on the evaluation and treatment of syndesmotic injuries.

Authors:  S Rammelt; P Obruba
Journal:  Eur J Trauma Emerg Surg       Date:  2014-11-12       Impact factor: 3.693

5.  Stable Versus Unstable Grade II High Ankle Sprains: A Prospective Study Predicting the Need for Surgical Stabilization and Time to Return to Sports.

Authors:  James D Calder; Richard Bamford; Aviva Petrie; Graham A McCollum
Journal:  Arthroscopy       Date:  2015-12-22       Impact factor: 4.772

6.  Complications of syndesmotic screw removal.

Authors:  Tim Schepers; Esther M M Van Lieshout; Mark R de Vries; Maarten Van der Elst
Journal:  Foot Ankle Int       Date:  2011-11       Impact factor: 2.827

7.  Adult ankle fractures--an increasing problem?

Authors:  C M Court-Brown; J McBirnie; G Wilson
Journal:  Acta Orthop Scand       Date:  1998-02

8.  Operative treatment of ankle fractures.

Authors:  U Lindsjö
Journal:  Acta Orthop Scand Suppl       Date:  1981
  8 in total
  1 in total

1.  Evidence-Based Surgical Treatment Algorithm for Unstable Syndesmotic Injuries.

Authors:  Markus Regauer; Gordon Mackay; Owen Nelson; Wolfgang Böcker; Christian Ehrnthaller
Journal:  J Clin Med       Date:  2022-01-10       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.